Filing Details
- Accession Number:
- 0000874716-25-000127
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-08-08 21:00:13
- Reporting Period:
- 2025-08-06
- Filing Date:
- 2025-08-08
- Accepted Time:
- 2025-08-08 21:00:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1800619 | Nimrata Hunt | One Idexx Drive Westbrook ME 04092 | Executive Vice President | No | Yes | No | No |
Transaction Summary
| Sold: | 7,143 shares | Avg. Price: $630.43 | Total Value: $4,503,163.48 |
| Number of Shares After Transactions: | 18,007 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-08-06 | 1,218 | $141.60 | 13,574 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-08-06 | 5,865 | $178.26 | 19,439 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-08-06 | 5,711 | $206.94 | 25,150 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-08-06 | 3,018 | $629.87 | 22,132 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-08-06 | 2,907 | $630.91 | 19,225 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-08-06 | 1,218 | $630.69 | 18,007 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2025-08-06 | 1,218 | $0.00 | 1,218 | $141.60 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2025-08-06 | 5,865 | $0.00 | 5,865 | $178.26 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2025-08-06 | 5,711 | $0.00 | 5,711 | $206.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-02-13 | No | 4 | M | Direct | |
| 0 | 2028-02-13 | No | 4 | M | Direct | |
| 0 | 2029-02-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 160 | Indirect | jointly with spouse |
Footnotes
- Includes a total of 28.7090 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
- Represents the weighted average price of the shares sold ranging from a low of $630.50 to a high of $630.94 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Grant of option to buy shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2018.
- Grant of option to buy shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2019.
- Grant of option to buy shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2020.
Billionaire Hedge Funds
